Neuro-oncology Program, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Cancer Causes Control. 2013 May;24(5):1025-31. doi: 10.1007/s10552-013-0178-0. Epub 2013 Mar 3.
Increased height and greater adiposity have been linked to an increased risk of many cancer types, though few large studies have examined these associations in glioma. We examined body weight and height as potential risk factors for glioma in a large US-based case-control study.
The analysis included 1,111 glioma cases and 1,096 community controls. In a structured interview, participants reported their height and weight at 21 years of age, lowest and highest weight in adulthood, and weight 1-5 years in the past.
Being underweight at age 21 (BMI < 18.5 kg/m(2)) was inversely associated with the risk of glioma development. This protective association was observed in both men and women, but reached statistical significance in women only (multivariate OR 0.68; 95 % CI 0.48, 0.96). When BMI at age 21 was assessed as a continuous variate, a small but significant increase in risk was observed per unit increase in kg/m(2) (OR 1.04; 95 % CI 1.02, 1.07). Adult height, recent body weight, and weight change in adulthood were not associated with glioma risk. All results were similar among never smokers and were consistent after stratifying by glioma subtype.
The present data suggest that a low body weight in early adulthood is associated with a reduced risk of glioma later in life. Results are consistent with previous studies in showing no material association of glioma risk with usual adult body weight. The present study does not support any association of adult stature with glioma risk.
身高增加和肥胖增加与多种癌症类型的风险增加有关,尽管很少有大型研究检查过这些关联在神经胶质瘤中的情况。我们在美国的一项大型病例对照研究中检查了体重和身高是否是神经胶质瘤的潜在危险因素。
该分析包括 1111 例神经胶质瘤病例和 1096 例社区对照。在一项结构化访谈中,参与者报告了他们 21 岁时的身高和体重、成年后最低和最高体重以及过去 1-5 年内的体重。
21 岁时体重不足(BMI < 18.5 kg/m2)与神经胶质瘤发展风险呈负相关。这种保护作用在男性和女性中均观察到,但仅在女性中具有统计学意义(多变量 OR 0.68;95 % CI 0.48,0.96)。当 21 岁时的 BMI 作为连续变量评估时,每增加 1 kg/m2,风险就会略有增加(OR 1.04;95 % CI 1.02,1.07)。成人身高、近期体重和成年期体重变化与神经胶质瘤风险无关。所有结果在从不吸烟者中相似,并且在按神经胶质瘤亚型分层后仍然一致。
目前的数据表明,成年早期的低体重与以后生活中神经胶质瘤风险降低有关。结果与以前的研究一致,表明神经胶质瘤风险与成年人的体重无实质性关联。本研究不支持成人身高与神经胶质瘤风险之间存在任何关联。